Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Friday, March 29, 2024 · 699,734,600 Articles · 3+ Million Readers

Autoimmune Disease Diagnosis Industry Trends Include Use Of Biosensors & Nano Biosensors For Rapid Detection

Autoimmune Disease Diagnosis Market Report 2021: COVID-19 Growth And Change To 2030

Autoimmune Disease Diagnosis Global Market Report 2021: COVID-19 Growth And Change To 2030

The Business Research Company’s Autoimmune Disease Diagnosis Global Market Report 2021: COVID-19 Growth And Change To 2030

LONDON, GREATER LONDON , UK, April 8, 2021 /EINPresswire.com/ -- Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports

Biosensors and nano biosensors for rapid detection is a novel tool for the detection of antibodies in the autoimmune disease diagnosis market. They are highly preferred because of low cost, high sensitivity, simple to use, multiplexing abilities and rapid diagnosis. Besides measuring the quantity of antibodies in human blood serum with extremely high sensitivity, it also quantifies the activity of antibodies as the assay employs portable optical label-free biosensors based on the spectral correlation interferometry. This point of care technology gives a more integrated, informative, timely and precise diagnosis of autoimmune diseases when compared to the conventional ones.

The autoimmune disease diagnosis market covered in this report is segmented by product into consumables & assay kits, instruments. The autoimmune disease diagnosis market is also segmented by test type into routine laboratory tests, autoantibodies tests, immunologic tests, other tests and by end-user into clinical laboratories, hospitals, other end-users.

Read More On The Global Autoimmune Disease Diagnosis Market Report:
https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-market-global-report-2020-30-covid-19-growth-and-change

The global autoimmune disease diagnosis market is expected to grow from $3.38 billion in 2020 to $4.15 billion in 2021 at a compound annual growth rate (CAGR) of 22.8%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The autoimmune disease market size is expected to reach $5.75 billion in 2025 at a CAGR of 8%.

Major players in the autoimmune disease therapeutics market are Thermo Fisher Scientific, Siemens Healthineers, Abbott, Danaher, Bio-Rad Laboratories, Trinity Biotech, Hycor Biomedical, Euroimmun AG, and Aesku Group GMBH & CO. KG.

Autoimmune Disease Diagnosis Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides autoimmune disease diagnosis market overview, forecast autoimmune disease diagnosis market size and growth for the whole market, autoimmune disease diagnosis market segments, and geographies, autoimmune disease diagnosis market trends, autoimmune disease diagnosis market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Autoimmune Disease Diagnosis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3231&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

Immunochemistry Diagnostic Devices And Equipment Global Market Report 2021: COVID-19 Implications And Growth to 2030
https://www.thebusinessresearchcompany.com/report/immunochemistry-diagnostic-devices-and-equipment-global-market-report

Prenatal Testing & Newborn Screening Global Market Report 2021: COVID-19 Growth And Change to 2030
https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report-2020-30-covid-19-growth-and-change

Cellular Immunotherapy Global Market Report 2021: COVID-19 Growth And Change to 2030
https://www.thebusinessresearchcompany.com/report/cellular-immunotherapy-global-market-report-2020-30-covid-19-growth-and-change

Oral Biologics And Biosimilars Market - By Therapeutic Mechanism (Tumor Necrosis Factor-Alpha Inhibitors, Lymphocyte Modulators, Interleukin Inhibitors, GPCR (insulin, growth hormone, parathyroid hormone) Modulators, Immunostimulants, Others), By Disease (Diabetes, Arthritis & Chron`s Disease, Cancer, Infectious Diseases, Other Autoimmune Diseases, Others Diseases), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies - Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilars-market

G-CSF (Granulocyte Colony Stimulating Factors) Market - By Type (Pegfilgrastim, Filgrastim, Lenograstim, Others), By Application (Oncology, Blood Disorders, Chronic and Autoimmune Disorders, Others), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/granulocyte-colony-stimulating-factors-market

Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release